cvot tirzepatide In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx SURPASS-CVOT trial: Tirzepatide was non-inferior
Description
View Full Profile Ron Avraham, MD Physiatry & Pain Medicine, Life Care Planner, IME Polaris Rehabilitation PLYMOUTH, Massachusetts Physical Medicine & Rehab, Pain Management - Medicine - PM&R, Life Care Planning, LCP, IME - Independent Medical Exam, Neck Pain, Back Pain, Sciatica, Radiculopathy, Spinal Stenosis, Musculoskeletal medicine, Chronic Pain, Osteoarthritis, Spine injections, Traumatic Brain Injury, TBI, Spinal Cord Injury, SCI, Complex regional pain syndrome, Amputation, Stroke Double Board-Certified PM&R (physiatry) physician, specializing in interventional pain management, non-surgical orthopedic care and musculoskeletal medicine, pain medicine and medical rehabilitation
What is compounded tirzepatide, and how is it different from Mounjaro or Zepbound
The medication curbed my cravings completely I feel more energetic than I have in 10 years." Amanda L
La motivacin del paciente es uno de los factores ms importantes para el xito
LBA 71 Tudik, P
two patients discontinued due to nausea Takeaway: Lower doses may improve tolerability, though weight loss trailed standard dosing
